Early prophylactic tx beneficial for hypertrophic cardiomyopathy

Early prophylactic tx beneficial for hypertrophic cardiomyopathy
Beta blockers are effective as an early prophylactic pharmacologic treatment for patients with mild hypertrophic cardiomyopathy who have exercise-induced left ventricular outflow tract obstruction, according to a study published in the Sept. 1 issue of The American Journal of Cardiology.

(HealthDay)—Beta blockers (BBs) are effective as an early prophylactic pharmacologic treatment for patients with mild hypertrophic cardiomyopathy (HC) who have exercise-induced left ventricular outflow tract (LVOT) obstruction, according to a study published in the Sept. 1 issue of The American Journal of Cardiology.

Stefano Nistri, M.D., Ph.D., of CMSR-Veneto Medica in Vicenza, Italy, and associates examined the benefits of BBs in a prospective study involving 27 patients with HC with mild or no symptoms of , without obstruction at rest, but with exercise-induced LVOT gradients of ≥30 mm Hg.

The researchers found that the mean post-exercise LVOT gradient was 87 ± 29 mm Hg. After an average of 12 months of BB treatment with or bisoprolol, the post-exercise LVOT gradient decreased significantly and was almost abolished in 52 percent of patients (0 to <30 mm Hg), considerably reduced in 33 percent (≥20 mm Hg reduction), and unchanged in 15 percent. Severe post-exercise obstruction persisted in 22 percent of treated patients, compared with 93 percent of untreated patients. Body mass index was increased among non-responders (hazard ratio, 2.03 per 1 kg/m²).

"In patients with HC with mild or no symptoms, treatment with BBs can prevent the development of LVOT obstruction triggered by physiologic exercise," the authors write. "These findings provide a rationale for the novel strategy of early prophylactic pharmacologic treatment with standard, well-tolerated doses of BBs in physically active patients with provocable gradients, aimed at effective prevention of the hemodynamic burden associated with dynamic obstruction."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Good transplant outcomes in hypertrophic cardiomyopathy

date Aug 17, 2012

(HealthDay) -- Post-heart transplant survival does not differ significantly between patients with hypertrophic cardiomyopathy (HC) and those with other types of heart disease, according to a study published in the Aug. 15 ...

Recommended for you

Cognitive impairment predicts worse outcome in heart failure

date 5 hours ago

Cognitive impairment predicts worse outcome in elderly heart failure patients, reveals research presented today at Heart Failure 2015 by Hiroshi Saito, a physiotherapist at Kameda Medical Centre in Kamogawa, Japan. Patients ...

1950s drug is future heart treatment

date May 22, 2015

Oxford University researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950.

Time is muscle in acute heart failure

date May 21, 2015

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.